|
1.
|
|
9 p, 1.3 MB |
Beyond copy number : A new, rapid, and versatile method for sequencing the entire SMN2 gene in SMA patients
/
Blasco-Pérez, Laura (Hospital Universitari Vall d'Hebron) ;
Paramonov, Ida (Hospital Universitari Vall d'Hebron) ;
Leno Colorado, Jordi (Hospital Universitari Vall d'Hebron) ;
Bernal, Sara (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Alias, L. (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Fuentes-Prior, Pablo (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Cusco, Ivon (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Tizzano, E.F. (Hospital Universitari Vall d'Hebron)
Spinal muscular atrophy (SMA) is caused by bi-allelic loss or pathogenic variants in the SMN1 gene. SMN2, the highly homologous copy of SMN1, is considered the major phenotypic modifier of the disease. [...]
2021 -  10.1002/humu.24200
Human mutation, Vol. 42 Núm. 6 (june 2021) , p. 787-795
|
|
|
2.
|
|
795.1 KB |
Genetic and phenotypic spectrum associated with IFIH1 gain-of-function
/
Rice, Gillian I. (University of Manchester) ;
Park, Sehoon (Boston Children's Hospital (Boston, Estats Units d'Amèrica)) ;
Gavazzi, Francesco (Children's Hospital of Philadelphia (Pennsilvània)) ;
Adang, Laura A. (Children's Hospital of Philadelphia (Pennsilvània)) ;
Ayuk, Loveline A. (Dumfries and Galloway Royal Infirmary) ;
Eyck, Lien Van (Institut Imagine (Paris, França)) ;
Seabra, Luis (Institut Imagine (Paris, França)) ;
Barrea, Christophe (Université de Liège) ;
Battini, Roberta (IRCCS Fondazione Stella Maris) ;
Belot, Alexandre (Université de Lyon) ;
Berg, Stefan (The Queen Silvia Children's Hospital) ;
de Villemeur, Thierry Billette (Sorbonne Université) ;
Bley, Annette E. (University Children's Hospital) ;
Blumkin, Lubov (Tel-Aviv University) ;
Boespflug-Tanguy, Odile (Centre de Référence Maladies Rares "Leucodystrophies") ;
Briggs, Tracy A. (St Mary's Hospital) ;
Brimble, Elise (Stanford University School of Medicine) ;
Dale, Russell C.. (University of Sydney) ;
Darin, Niklas (The Queen Silvia Children's Hospital) ;
Debray, François-Guillaume (Université de Liège) ;
De Giorgis, Valentina (IRCCS Mondino Foundation) ;
Denecke, Jonas (University Medical Center Hamburg Eppendorf) ;
Doummar, Diane (Hôpital Armand Trousseau (París, França)) ;
Hagelsrum, Gunilla Drake af (PeThe Queen Silvia Children's Hospital) ;
Eleftheriou, Despina (University College London (UCL)) ;
Estienne, Margherita (Istituto Neurologico Carlo Besta) ;
Fazzi, Elisa (University of Brescia. Department of Experimental and Clinical Sciences) ;
Feillet, François (Centre de Référence des maladies métaboliques de Nancy (França)) ;
Galli, Jessica (University of Brescia. Department of Experimental and Clinical Sciences) ;
Hartog, Nicholas (Michigan State University College of Human Medicine) ;
Harvengt, Julie (University of Liège. Department of Medical Genetics) ;
Heron, Bénédicte (Hôpital Trousseau (París, França). Centre Référence des Maladies Lysosomales) ;
Heron, Delphine (Groupe Hospitalier Pitié-Salpêtrière (París, França). UF Génétique Médicale et Centre de Référence "Déficiences Intellectuelles) ;
Kelly, Diedre A. (Birmingham Women's and Children's Hospital (Regne Unit)) ;
Lev, Dorit (The Rina Mor Institute of Medical Genetics (Holon, Israel)) ;
Levrat, Virginie (Centre Hospitalier Annecy Genevois (Pringy, França)) ;
Livingston, John H. (Leeds General Infirmary (Leeds, Regne Unit)) ;
Marti, Itxaso (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ;
Mignot, Cyril (GH Pitié-Sapêtrière (París, França). Departement de Génétique & Centre de Référence Déficience Intellectuelle de cause rare) ;
Mochel, Fanny (Sorbonne Universités. Institut du Cerveau et de la Moelle épinière) ;
Nougues, Marie-Christine (Hôpital Armand Trousseau (París, França)) ;
Oppermann, Ilena (University Medical Center Hamburg Eppendorf) ;
Pérez-Dueñas, Belén (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Popp, Bernt (Friedrich-Alexander-Universität Erlangen-Nürnberg. Institute of Human Genetics) ;
Rodero, Mathieu P. (Institut Imagine (París, França). Laboratory of Neurogenetics and Neuroinflammation) ;
Rodriguez, Diana (Hôpital Trousseau (París, França). Centre Référence des Maladies Lysosomales) ;
Saletti, Veronica (Fondazione IRCCS Istituto Neurologico Carlo Besta (Milà, Itàlia)) ;
Sharpe, Cia (Starship Children's Hospital (Auckland, Nova Zelanda)) ;
Tonduti, Davide (V. Buzzi Children's Hospital (Milà, Itàlia)) ;
Vadlamani, Gayatri (Leeds General Infirmary (Leeds, Regne Unit)) ;
Haren, Keith Van (Stanford University School of Medicine. Department of Neurology) ;
Vila, Miguel Tomas (Hospital Universitari i Politècnic La Fe (València)) ;
Vogt, Julie (West Midlands Regional Clinical Genetics Service (Regne Unit)) ;
Wassmer, Evangeline (Birmingham Women's and Children's Hospital (Regne Unit)) ;
Wiedemann, Arnaud (Centre de Référence des maladies métaboliques de Nancy (França)) ;
Wilson, Callum J. (Starship Children's Hospital (Auckland, Nova Zelanda)) ;
Zerem, Ayelet (Tel-Aviv Universitym. Sackler Faculty of Medicine) ;
Zweier, Christiane (Friedrich-Alexander-Universität Erlangen-Nürnberg) ;
Zuberi, Sameer M. (University of Glasgow. School of Medicine) ;
Orcesi, Simona (University of Pavia. Department of Brain and Behavioural Sciences) ;
Vanderver, Adeline L. (Children's Hospital of Philadelphia (Pennsilvània)) ;
Hur, Sun (Boston Children's Hospital (Boston, Estats Units d'Amèrica)) ;
Crow, Yanick J. (University of Edinburgh. Institute of Genetics and Molecular Medicine) ;
Universitat Autònoma de Barcelona
IFIH1 gain-of-function has been reported as a cause of a type I interferonopathy encompassing a spectrum of autoinflammatory phenotypes including Aicardi-Goutières syndrome and Singleton Merten syndrome. [...]
2020 - 10.1002/humu.23975
Human mutation, Vol. 41 (january 2020) , p. 837-849
|
|
|
3.
|
|
14 p, 2.3 MB |
eDiVA-Classification and prioritization of pathogenic variants for clinical diagnostics
/
Bosio, Mattia (Barcelona Supercomputing Center) ;
Drechsel, Oliver (Robert Koch Institute) ;
Rahman, Rubayte (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Muyas, Francesc (Universitat Pompeu Fabra) ;
Rabionet, Raquel (Institut de Recerca Sant Joan de Déu) ;
Bezdan, Daniela (Universitat Pompeu Fabra) ;
Domenech Salgado, Laura (Universitat Pompeu Fabra) ;
Hor, Hyun (University Hospital Zurich (Suïssa)) ;
Schott, Jean-Jacques (Service de Cardiologie. L'institut du thorax. CHU Nantes) ;
Munell Casadesus, Francina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Colobrán Oriol, Roger (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Macaya Ruiz, Alfons (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Estivill, Xavier (Women's Health Dexeus) ;
Ossowski, Stephan (Institute of Medical Genetics and Applied Genomics. University of Tübingen) ;
Universitat Autònoma de Barcelona
Mendelian diseases have shown to be an and efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. [...]
2019 - 10.1002/humu.23772
Human mutation, Vol. 40 Núm. 7 (july 2019) , p. 865-878
|
|
|
4.
|
|
13 p, 955.5 KB |
TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
/
van der Zee, Julie (University of Antwerp) ;
Gijselinck, Ilse (University of Antwerp) ;
Van Mossevelde, Sara (University Hospital Antwerp (Bèlgica)) ;
Perrone, Federica (University of Antwerp) ;
Dillen, Lubina (University of Antwerp) ;
Heeman, Bavo (University of Antwerp) ;
Bäumer, Veerle (University of Antwerp) ;
Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ;
De Bleecker, Jan (Universitair Ziekenhuis Gent) ;
Baets, Jonathan (University Hospital Antwerp (Bèlgica)) ;
Gelpi, Ellen (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Rojas-Garcia, Ricard (Universitat Autònoma de Barcelona) ;
Clarimón, Jordi (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Lleó Bisa, Alberto (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Diehl-Schmid, Janine (Technische Universität München) ;
Alexopoulos, Panagiotis (Technische Universität München) ;
Perneczky, Robert (West London Mental Health Trust) ;
Synofzik, Matthis (German Research Center for Neurodegenerative Diseases (DZNE)) ;
Just, Jennifer (German Research Center for Neurodegenerative Diseases (DZNE)) ;
Schöls, Ludger (German Research Center for Neurodegenerative Diseases (DZNE)) ;
Graff, Caroline (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Thonberg, Håkan (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Borroni, Barbara (University of Brescia) ;
Padovani, Alessandro (University of Brescia) ;
Jordanova, Albena (Medical University-Sofia) ;
Sarafov, Stayko (Medical University-Sofia) ;
Tournev, Ivailo (New Bulgarian University) ;
de Mendonça, Alexandre (University of Lisbon) ;
Miltenberger-Miltényi, Gabriel (University of Lisbon) ;
Simões do Couto, Frederico (University of Lisbon) ;
Ramirez, Alfredo (University of Cologne) ;
Jessen, Frank (German Center for Neurodegenerative Diseases (DZNE)) ;
Heneka, Michael T. (University of Bonn) ;
Gómez-Tortosa, Estrella (Hospital Universitario Fundación Jiménez Díaz) ;
Danek, Adrian (German Center for Neurodegenerative Diseases (DZNE)) ;
Cras, Patrick (University Hospital Antwerp (Bèlgica)) ;
Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ;
De Jonghe, Peter (University Hospital Antwerp (Bèlgica)) ;
De Deyn, Peter Paul (University Hospital Antwerp (Bèlgica)) ;
Sleegers, Kristel (University of Antwerp) ;
Cruts, Marc (University of Antwerp) ;
Van Broeckhoven, Christine (University of Antwerp) ;
Goeman, Johan (University Hospital Antwerp (Bèlgica)) ;
Nuytten, Dirk (University Hospital Antwerp (Bèlgica)) ;
Smets, Katrien (University Hospital Antwerp (Bèlgica)) ;
Robberecht, Wim (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Damme, Philip Van (University Hospitals Gasthuisberg (Leuven, Bélgica)) ;
Bleecker, Jan De (Universitair Ziekenhuis Gent) ;
Santens, Patrick (Universitair Ziekenhuis Gent) ;
Dermaut, Bart (Universitair Ziekenhuis Gent) ;
Versijpt, Jan (University Hospital Brussels) ;
Michotte, Alex (University Hospital Brussels) ;
Ivanoiu, Adrian (Saint-Luc University Hospital) ;
Deryck, Olivier (General Hospital Sint-Jan Brugge) ;
Bergmans, Bruno (General Hospital Sint-Jan Brugge) ;
Delbeck, Jean (General Hospital Sint-Maria) ;
Bruyland, Marc (General Hospital Glorieux Ronse) ;
Willems, Christiana (Jessa Hospital) ;
Salmon, Eric (University of Liège and Memory Clinic) ;
Pastor, Pau (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ;
Ortega-Cubero, Sara (Deparment of Neurology, Complejo Asistencial Universitario de Palencia) ;
Benussi, Luisa (Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ;
Ghidoni, Roberta (Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ;
Binetti, Giuliano (MAC Memory Center and Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ;
Hernández, Isabel (Institut Català de Neurociènces Aplicades) ;
Boada, Mercè (Institut Català de Neurociènces Aplicades) ;
Ruiz Laza, Agustín (Institut Català de Neurociènces Aplicades) ;
Sorbi, Sandro (Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence) ;
Nacmias, Benedetta (Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence) ;
Bagnoli, Silvia (Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence) ;
Sorbi, Sandro (IRCCS Don Carlo Gnocchi Scandicci) ;
Sánchez Valle, Raquel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Llado Plarrumani, Albert (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Santana, Isabel (University of Coimbra) ;
Rosário Almeida, Maria (University of Coimbra) ;
Frisoni, Giovanni B.. (Hôpitaux Universitaires de Genève et Université de Genève, Genève, Switzerland and IRCCS Fatebenefratelli) ;
Maetzler, Walter (Hertie Institute for Clinical Brain Research) ;
Matej, Radoslav (Charles University. Faculty of Medicine in Hradec Králové) ;
Fraidakis, Matthew J. (NeuroRARE Centre for Rare and Genetic Neurological & Neuromuscular Diseases & Neurogenetics) ;
Kovacs, Gabor G. (Medical University of Vienna) ;
Fabrizi, Gian Maria (University of Verona) ;
Testi, Silvia (University of Verona) ;
Universitat Autònoma de Barcelona
We investigated the mutation spectrum of the TANK-Binding Kinase 1 (TBK1) gene and its associated phenotypic spectrum by exonic resequencing of TBK1 in a cohort of 2,538 patients with frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), or FTD plus ALS, ascertained within the European Early-Onset Dementia Consortium. [...]
2017 - 10.1002/humu.23161
Human mutation, Vol. 38, Issue 3 (March 2017) , p. 297-309
|
|
|
5.
|
|
9 p, 1.2 MB |
From Wet-Lab to Variations : Concordance and Speed of Bioinformatics Pipelines for Whole Genome and Whole Exome Sequencing
/
Laurie, Steve (Centre de Regulació Genòmica) ;
Fernández, Marcos (Centre de Regulació Genòmica) ;
Marco-Sola, Santiago (Universitat Pompeu Fabra) ;
Trotta, Jean-Rémi (Universitat Pompeu Fabra) ;
Camps, Jordi (Centre de Regulació Genòmica) ;
Chacón, Alejandro (Universitat Autònoma de Barcelona) ;
Espinosa, Antonio (Universitat Autònoma de Barcelona. Departament d'Arquitectura de Computadors i Sistemes Operatius) ;
Gut, Marta (Centre de Regulació Genòmica) ;
Gut, Ivo (Universitat Pompeu Fabra) ;
Heath, Simon (Universitat Pompeu Fabra) ;
Beltran i Agulló, Sergi (Centre de Regulació Genòmica)
As whole genome sequencing becomes cheaper and faster, it will progressively substitute targeted next-generation sequencing as standard practice in research and diagnostics. However, computing cost-performance ratio is not advancing at an equivalent rate. [...]
2016 - 10.1002/humu.23114
Human mutation, Vol. 37, Issue 12 (December 2016) , p. 1263-1271
|
|
|
6.
|
|
10 p, 498.4 KB |
Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort
/
Cacace, Rita (University of Antwerp) ;
Van den Bossche, Tobi (University Hospital Antwerp (Bèlgica)) ;
Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ;
Geerts, Nathalie (University of Antwerp) ;
Laureys, Annelies (University of Antwerp) ;
Dillen, Lubina (University of Antwerp) ;
Graff, Caroline (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Thonberg, Håkan (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Chiang, Huei-Hsin (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Pastor, Pau (Instituto de Salud Carlos III) ;
Ortega-Cubero, Sara (Instituto de Salud Carlos III) ;
Pastor, Maria A. (Universidad de Navarra. Facultad de Medicina) ;
Diehl-Schmid, Janine (Technische Universität München) ;
Alexopoulos, Panagiotis (Technische Universität München) ;
Benussi, Luisa (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ;
Ghidoni, Roberta (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ;
Binetti, Giuliano (Istituto Centro San Giovanni di Dio-Fatebenefratelli) ;
Nacmias, Benedetta (University of Florence) ;
Sorbi, Sandro (University of Florence) ;
Sanchez-Valle, Raquel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Llado Plarrumani, Albert (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Gelpi, Ellen (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Almeida, Maria Rosário (University of Coimbra) ;
Santana, Isabel (University of Coimbra) ;
Tsolaki, Magda (Aristotle University of Thessaloniki) ;
Koutroumani, Maria (Aristotle University of Thessaloniki) ;
Clarimón, Jordi (Universitat Autònoma de Barcelona) ;
Lleó Bisa, Alberto (Universitat Autònoma de Barcelona) ;
Fortea, Juan (Universitat Autònoma de Barcelona) ;
de Mendonça, Alexandre (University of Lisbon) ;
Martins, Madalena (University of Lisbon) ;
Borroni, Barbara (University of Brescia) ;
Padovani, Alessandro (University of Brescia) ;
Matej, Radoslav (Thomayer Hospital) ;
Rohan, Zdenek (Third Medical Faculty of Charles University in Prague) ;
Vandenbulcke, Mathieu (University of Leuven) ;
Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ;
De Deyn, Peter Paul (University Hospital Antwerp (Bèlgica)) ;
Cras, Patrick (University Hospital Antwerp (Bèlgica)) ;
van der Zee, Julie (University of Antwerp) ;
Sleegers, Kristel (University of Antwerp) ;
Van Broeckhoven, Christine (University of Antwerp)
Rare variants in the phospholipase D3 gene (PLD3) were associated with increased risk for late-onset Alzheimer disease (LOAD). We identified a missense mutation in PLD3 in whole-genome sequence data of a patient with autopsy confirmed Alzheimer disease (AD) and onset age of 50 years. [...]
2015 - 10.1002/humu.22908
Human mutation, Vol. 36 (october 2015) , p. 1226-1235
|
|
|
7.
|
|
13 p, 1.5 MB |
Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles
/
Osorio, Ana (Centro Nacional de Investigaciones Oncológicas) ;
Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Fernández, Victoria (Centro Nacional de Investigaciones Oncológicas) ;
Barroso, Alicia (Centro Nacional de Investigaciones Oncológicas) ;
De la Hoya, Miguel (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Caldes, Trinidad (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Lasa, Adriana (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Ramon y Cajal, Teresa (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Santamariña, Marta (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Vega, Ana (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Quiles, Francisco (Institut Català d'Oncologia) ;
Lázaro, Conxi (Institut Català d'Oncologia) ;
Diez, Orland (Vall d'Hebron Institut d'Oncologia) ;
Fernández García, Daniel (Instituto de Biología Molecular y Celular del Cancer) ;
González-Sarmiento, Rogelio (Instituto de Biología Molecular y Celular del Cancer) ;
Durán, Mercedes (Universidad de Valladolid. Instituto de Biología y Genética Molecular) ;
Fernández Piqueras, José (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Marín, Maria (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Pujol i Calvet, M. Roser (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Benitez, Javier (Centro de Investigación Biomédica en Red de Enfermedades Raras) ;
Universitat Autònoma de Barcelona
Recently, it has been reported that biallelic mutations in the ERCC4 (FANCQ) gene cause Fanconi anemia (FA) subtype FA-Q. To investigate the possible role of ERCC4 in breast and ovarian cancer susceptibility, as occurs with other FA genes, we screened the 11 coding exons and exon-intron boundaries of ERCC4 in 1573 index cases from high-risk Spanish familial breast and ovarian cancer pedigrees that had been tested negative for BRCA1 and BRCA2 mutations and 854 controls. [...]
2013 - 10.1002/humu.22438
Human mutation, Vol. 34, issue 12 (Dec. 2013) , p.1615-8
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
